Items where Funder is Celgene Corporation.

[up] Up a level
Group by: Grant number | Institution | No Grouping
Jump to: A25447 | CTUQQR-Dec22/100002 | MERCK - MYELOMA XI | RV-MM-PI-0251
Number of items: 7.

A25447

Orgueira, A.M., Perez, M.S.G., D'Agostino, M. et al. (30 more authors) (2025) Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform. HemaSphere, 9 (10). e70228. ISSN 2572-9241

Reed, M., Cairns, D.A. orcid.org/0000-0002-2338-0179, Pawlyn, C. et al. (13 more authors) (2023) The Impact of Epstein-Barr Virus Infection on Second Cancer Development in Newly Diagnosed Myeloma Patients Treated with Lenalidomide in the UK NCRI Myeloma XI Trial. In: Blood. 65th ASH Annual Meeting and Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 3366-3368.

CTUQQR-Dec22/100002

Orgueira, A.M., Perez, M.S.G., D'Agostino, M. et al. (30 more authors) (2025) Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform. HemaSphere, 9 (10). e70228. ISSN 2572-9241

MERCK - MYELOMA XI

Orgueira, A.M., Perez, M.S.G., D'Agostino, M. et al. (30 more authors) (2025) Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform. HemaSphere, 9 (10). e70228. ISSN 2572-9241

Reed, M., Cairns, D.A. orcid.org/0000-0002-2338-0179, Pawlyn, C. et al. (13 more authors) (2023) The Impact of Epstein-Barr Virus Infection on Second Cancer Development in Newly Diagnosed Myeloma Patients Treated with Lenalidomide in the UK NCRI Myeloma XI Trial. In: Blood. 65th ASH Annual Meeting and Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 3366-3368.

RV-MM-PI-0251

Orgueira, A.M., Perez, M.S.G., D'Agostino, M. et al. (30 more authors) (2025) Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform. HemaSphere, 9 (10). e70228. ISSN 2572-9241

Reed, M., Cairns, D.A. orcid.org/0000-0002-2338-0179, Pawlyn, C. et al. (13 more authors) (2023) The Impact of Epstein-Barr Virus Infection on Second Cancer Development in Newly Diagnosed Myeloma Patients Treated with Lenalidomide in the UK NCRI Myeloma XI Trial. In: Blood. 65th ASH Annual Meeting and Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 3366-3368.

This list was generated on Fri Oct 31 03:57:36 2025 GMT.